Abattis Announces Vergence Update (PR)

0 Responses Abattis News | Vergence

Vancouver, British Columbia / Newsfile Corp. / August 15, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to provide an update on its wholly-owned subsidiary, Vergence Visionary Bioceuticals (“Vergence”), which is a nutraceutical marketing and brand specialist firm focused on bringing innovative health products to market. New Brand Partnerships […]

Abattis Adds New Product Line to Wholly-Owned Subsidiary Vergence Naturals Distribution Portfolio (PR)

0 Responses Abattis News | Vergence

Vancouver, British Columbia / Newsfile Corp. / August 11, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) (the “Company” or “Abattis“) is pleased to announce it has reached a deal with Jonny Hetherington Essentials for major distribution of their products throughout North America and potentially Asia, through its wholly-owned subsidiary, Vergence Visionary Bioceuticals (“Vergence” or […]

Abattis Expands and Strengthens Its Asian Distribution Sales Channels (PR)

0 Responses Abattis News | Management | Vergence

Vancouver, British Columbia / Newsfile Corp. / July 25, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce the appointment of Mr. Wei Ma to oversee export and business development in Asia, in an effort to further expand and strengthen the Company’s Asian distribution channels. Mr. Ma has […]

Abattis Obtains DTC Eligibility (PR)

0 Responses Abattis News | Vergence

Vancouver, British Columbia / Newsfile Corp. / July 17, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that it has obtained Depository Trust Company (“DTC”) eligibility in the United States (“US”). The DTC is a stock depository and facilitates electronic trading in the US. When shares are […]

Abattis Provides Company Update (PR)

0 Responses Abattis News | Northern Vine | Raybot | Vergence

Vancouver, British Columbia / Newsfile Corp. / June 13, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to provide an update of recent developments and achievements. Testing Revenues at Northern Vine Labs Since the launch of its first lab in May of 2017, the Company’s subsidiary, Northern Vine Canada […]